Rivian Spinoff Making Small EVs Valued at $1 Billion
The venture firm put $200 million into the business, known as Also Inc., at a $1 billion post-money valuation, said the people, who asked not to be identified discussing nonpublic details.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
26 minutes ago
- Bloomberg
US Pauses Restart of Mexican Cattle Trade on Parasitic Fly Fears
The US has halted livestock imports from Mexico on concerns over the spread of a parasitic fly, just days after the trade resumed. Agriculture Secretary Brooke Rollins 'ordered the closure of livestock trade through southern ports of entry effectively immediately' to protect American cattle and the nation's food supply, according to a statement from the US Department of Agriculture late Wednesday.
Bloomberg
30 minutes ago
- Bloomberg
Top CEOs Want Canada to Build a Strategic Minerals Reserve for Defense
Canada should become a world leader in producing and processing raw materials for military equipment and defense systems, according to an influential business group. The Business Council of Canada urged the government to work with other NATO members to create a 'critical mineral reserve for defense technology and military purposes,' helping allies lock in a stable supply of key materials amid the threat of export controls and limited inventories.
Yahoo
30 minutes ago
- Yahoo
Myomo Reveals its $100 Revenue Goal During Investor Day
Myomo, Inc. (NYSE:MYO) is one of the . On June 18, the company held an Investor and Analyst Day to assess the company's business model and long-term aspirations. The company cited its Q1 FY2025 performance and mentioned that its lead generation capabilities helped recover the challenges faced earlier in the quarter. Myomo's management highlighted that prospective MyoPro patients are an untapped market, and the company is yet to reach saturation with its advertising. Kutlayev Dmitry/ The company also presented its goal of $100 million in annual revenue by 2028. Of this, $15 million of revenue is to come from international customers and $20 million from its O&P channel. Myomo, Inc. (NYSE:MYO) is a wearable robotics company that offers functionality to patients suffering from neurological disorders and upper limb paralysis. While we acknowledge the potential of MYO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
